In this episode of Axrem Insights, CEO Sally Edgington is joined by Holly Ruddock, Jack Bond and value-based procurement expert Brian Mangan, CEO of Luach Consulting Group, to unpack what value-based procurement really means for the NHS and industry. Moving beyond buzzwords, the panel explores how procurement can shift from a narrow focus on price to a broader assessment of patient pathways, long-term outcomes, efficiency gains and environmental impact. At its heart, value-based procurement is about delivering tangible, measurable benefits that improve care while making smarter use of limited resources.

The discussion tackles common barriers including siloed budgets, data access, cultural resistance and the perception that value-based approaches cost more. The panel highlights the growing policy momentum behind the agenda, including pilots and increased focus on outcomes, and makes the case that now is the time for suppliers to build evidence, develop case studies and reframe conversations with procurement teams. For AXREM members and NHS stakeholders alike, this episode offers a practical and optimistic look at how collaboration, communication and better questions can unlock real system-wide value.

AXREM Value Based Procurement Paper

Join AXREM and Convenzis at Radvision South at the ETC Venues in London on the 8th of July. Book your ticket here

Join us for the AXREM External Stakeholders Conference on 14th of October at the Royal society of Medicine in London. Book your ticket here

Thanks for listening to this week's episode

To find out more about AXREM check out our website HERE
If you are interested in joining AXREM as a member CLICK HERE
To contact us CLICK HERE

And join us next time for more insights from industry.